Clinical response after intradermal immature dendritic cell vaccination in metastatic melanoma is associated with immune response to particulate antigen.

MLA

Smithers, Mark, et al. “Clinical Response after Intradermal Immature Dendritic Cell Vaccination in Metastatic Melanoma Is Associated with Immune Response to Particulate Antigen.” Cancer Immunology, Immunotherapy : CII, vol. 52, no. 1, Jan. 2003, pp. 41–52. EBSCOhost, https://doi.org/10.1007/s00262-002-0318-y.

APA

Smithers, M., O’Connell, K., MacFadyen, S., Chambers, M., Greenwood, K., Boyce, A., Abdul-Jabbar, I., Barker, K., Grimmett, K., Walpole, E., & Thomas, R. (2003). Clinical response after intradermal immature dendritic cell vaccination in metastatic melanoma is associated with immune response to particulate antigen. Cancer Immunology, Immunotherapy : CII, 52(1), 41–52. https://doi.org/10.1007/s00262-002-0318-y

Chicago

Smithers, Mark, Kathleen O’Connell, Susan MacFadyen, Melita Chambers, Kathryn Greenwood, Amanda Boyce, Ibtissam Abdul-Jabbar, et al. 2003. “Clinical Response after Intradermal Immature Dendritic Cell Vaccination in Metastatic Melanoma Is Associated with Immune Response to Particulate Antigen.” Cancer Immunology, Immunotherapy : CII 52 (1): 41–52. doi:10.1007/s00262-002-0318-y.